Lamassa M, Di Carlo A, Pracucci G, Basile A M, Trefoloni G, Vanni P, Spolveri S, Baruffi M C, Landini G, Ghetti A, Wolfe C D, Inzitari D
Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy.
Stroke. 2001 Feb;32(2):392-8. doi: 10.1161/01.str.32.2.392.
The role of atrial fibrillation (AF) as a determinant of stroke outcome is not well established. Studies focusing on this topic relied on relatively small samples of patients, scarcely representative of the older age groups. We aimed at evaluating clinical characteristics, care, and outcome of stroke associated with AF in a large European sample.
In a European Concerted Action involving 7 countries, 4462 patients hospitalized for first-in-a-lifetime stroke were evaluated for demographics, risk factors, clinical presentation, resource use, and 3-month survival, disability (Barthel Index), and handicap (Rankin scale).
AF was present in 803 patients (18.0%). AF patients, compared with those without AF, were older, were more frequently female, and more often had experienced a previous myocardial infarction; they were less often diabetics, alcohol consumers, and smokers (all P:<0.001). At 3 months, 32.8% of the AF patients were dead compared with 19.9% of the non-AF patients (P:<0.001). With control for baseline variables, AF increased by almost 50% the probability of remaining disabled (multivariate odds ratio 1.43, 95% CI 1.13 to 1.80) or handicapped (multivariate odds ratio 1.51, 95% CI 1.13 to 2.02). Before stroke, only 8.4% of AF patients were on anticoagulants. The chance of being anticoagulated was reduced by 4% per year of increasing age. AF patients underwent CT scan and other diagnostic procedures less frequently and received less physiotherapy or occupational therapy.
Stroke associated with AF has a poor prognosis in terms of death and function. Prevention and care of stroke with AF is a major challenge for European health systems.
心房颤动(AF)作为卒中预后的决定因素,其作用尚未完全明确。针对该主题的研究依赖于相对较小的患者样本,很难代表老年人群体。我们旨在评估一个大型欧洲样本中与AF相关的卒中的临床特征、治疗及预后。
在一项涉及7个国家的欧洲协同行动中,对4462例首次发生卒中住院的患者进行了人口统计学、危险因素、临床表现、资源利用以及3个月生存率、残疾情况(Barthel指数)和残障情况(Rankin量表)的评估。
803例患者(18.0%)存在AF。与无AF的患者相比,AF患者年龄更大,女性更为常见,既往心肌梗死发生率更高;糖尿病患者、饮酒者和吸烟者较少(所有P值均<0.001)。3个月时,32.8%的AF患者死亡,而无AF患者的死亡率为19.9%(P<0.001)。在对基线变量进行控制后,AF使残疾(多变量优势比1.43,95%可信区间1.13至1.80)或残障(多变量优势比1.51,95%可信区间1.13至2.02)的可能性增加了近50%。卒中前,只有8.4%的AF患者接受抗凝治疗。随着年龄每增加一岁,接受抗凝治疗的几率降低4%。AF患者接受CT扫描和其他诊断检查的频率较低,接受物理治疗或职业治疗也较少。
就死亡和功能而言,与AF相关的卒中预后较差。对伴有AF的卒中进行预防和治疗是欧洲卫生系统面临的一项重大挑战。